Literature DB >> 20699333

Association between occupational exposure levels of antineoplastic drugs and work environment in five hospitals in Japan.

Jin Yoshida1, Shigeki Koda, Shozo Nishida, Toshiaki Yoshida, Keiko Miyajima, Shinji Kumagai.   

Abstract

PURPOSE: The aim of the present study was to evaluate the measurement of contamination by antineoplastic drugs for safer handling of such drugs by medical workers. We investigated the relationship between the contamination level of antineoplastic drugs and the conditions of their handling.
METHODS: Air samples and wipe samples were collected from equipment in the preparation rooms of five hospitals (hospitals A-E). These samples were subjected to measurement of the amounts of cyclophosphamide (CPA), fluorouracil (5FU), gemcitabine (GEM), and platinum-containing drugs (Pt). Twenty-four-hour urine samples were collected from the pharmacists who handled or audited, the antineoplastic drugs were analyzed for CPA and Pt.
RESULTS: Pt was detected from air samples inside BSC in hospital B. Antineoplastic drugs were detected from wipe samples of the BSC in hospitals A, B, D, and E and of other equipment in the preparation rooms in hospitals A, B, C, and D. Cyclophosphamide and 5FU were detected from wipe samples of the air-conditioner filter in hospital A, and CPA was detected from that in hospital D. Cyclophosphamide was detected from urine samples of workers in hospitals B, D, and E.
CONCLUSION: The contamination level of antineoplastic drugs was suggested to be related with the amount of drugs handled, cleaning methods of the equipment, and the skill level of the technique of maintaining negative pressure inside a vial. In order to reduce the contamination and exposure to antineoplastic drugs in the hospital work environment very close to zero, comprehensive safety precautions, including adequate mixing and cleaning methods was required in addition to BSC and closed system device.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20699333     DOI: 10.1177/1078155210380485

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN: 1078-1552            Impact factor:   1.809


  16 in total

Review 1.  Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence.

Authors:  Thomas H Connor; Christina C Lawson; Martha Polovich; Melissa A McDiarmid
Journal:  J Occup Environ Med       Date:  2014-09       Impact factor: 2.162

2.  Hazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing process.

Authors:  Luci A Power; Paul J M Sessink; Kathy Gesy; Flay Charbonneau
Journal:  Hosp Pharm       Date:  2014-04

3.  Safe handling of cytotoxics: guideline recommendations.

Authors:  A C Easty; N Coakley; R Cheng; M Cividino; P Savage; R Tozer; R E White
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

4.  Environmental contamination with hazardous drugs in quebec hospitals.

Authors:  Jean-François Bussières; Cynthia Tanguay; Karine Touzin; Eric Langlois; Michel Lefebvre
Journal:  Can J Hosp Pharm       Date:  2012-11

Review 5.  Applicability of the comet assay in evaluation of DNA damage in healthcare providers' working with antineoplastic drugs: a systematic review and meta-analysis.

Authors:  Mohammad Javad Zare Sakhvidi; Mohammad Hajaghazadeh; Mehrdad Mostaghaci; Amir Houshang Mehrparvar; Fariba Zare Sakhvidi; Elham Naghshineh
Journal:  Int J Occup Environ Health       Date:  2016-04-25

Review 6. 

Authors:  Céline Poupeau; Christel Roland; Jean-François Bussières
Journal:  Can J Hosp Pharm       Date:  2016-10-31

7.  Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: Methodology and recommendations.

Authors:  Thomas H Connor; Matthew D Zock; Amy H Snow
Journal:  J Occup Environ Hyg       Date:  2016-09       Impact factor: 2.155

8.  Occupational exposure to chemotherapy of pharmacy personnel at a single centre.

Authors:  Raveena Ramphal; Tejinder Bains; Geneviève Goulet; Régis Vaillancourt
Journal:  Can J Hosp Pharm       Date:  2015 Mar-Apr

Review 9.  Meta-analysis of chromosomal aberrations as a biomarker of exposure in healthcare workers occupationally exposed to antineoplastic drugs.

Authors:  Christine Roussel; Kristine L Witt; Peter B Shaw; Thomas H Connor
Journal:  Mutat Res Rev Mutat Res       Date:  2017-08-24       Impact factor: 5.657

10.  Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device.

Authors:  Paul J M Sessink; Jason Trahan; Joseph W Coyne
Journal:  Hosp Pharm       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.